Weight-loss jabs linked to lower cancer risk compared with insulin—new study

Obesity increases the risk of developing a number of cancers, so it stands to reason that drugs that reduce body weight should also reduce the risk of developing these cancers. Researchers in the US wanted to know if weight-loss drugs known as GLP-1 agonists reduced the risk of people getting any of the 13 cancers associated with obesity. Their results were recently published in JAMA Network Open. GLP-1 is a hormone produced by your gut after eating a meal that signals you are full. GLP-1 drugs deliver synthetic GLP-1, which Read More

Related posts:

  1. Weight-loss jabs linked to lower cancer risk compared with insulin—new study
  2. Mediterranean diet linked to lower risk of mortality, especially from cardiovascular disease, in cancer survivors
  3. Healthy weight loss could lower your odds for cancer
  4. New study finds 40% of cancer cases and almost half of all deaths in the US linked to modifiable risk factors
  5. Rare predicted loss-of-function variants, polygenic risk score linked to risk of A-fib
  6. E-cigarette use linked to lower use of lung cancer screening
  7. Popular prescription weight loss drugs linked to uncommon blindness condition
  8. Familial endocrine diseases linked to increased risk of pregnancy loss, new research shows

Leave a Reply

Your email address will not be published. Required fields are marked *